Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis.

13 , 14 In accordance with these data, we found that patients with previous stroke and those with previous disability had higher cfDNA levels, which may indicate a sustained inflammatory response or a greater level of cell death in these patients, although these results did not reach statistical significance.

also in 111,027 other papers